Equities

GemPharmatech Co Ltd

688046:SHH

GemPharmatech Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)11.11
  • Today's Change-0.12 / -1.07%
  • Shares traded1.63m
  • 1 Year change-36.22%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue622517394
OPERATING EXPENSES
Cost of revenue total203150101
Selling, general and admin. expenses, total212183143
Depreciation/amortization2.12----
Unusual expense(income)2013--
Other operating expenses, total(44)(62)(35)
Total operating expense458343251
Operating income164174143
Other, net(2.4)(0.27)0.05
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes161174143
Provision for income taxes2.379.0418
Net income after taxes159165125
Minority interest------
Net income before extra. Items159165125
Total extraordinary items------
Net income159165125
Inc.avail. to common excl. extra. Items159165125
Inc.avail. to common incl. extra. Items159165125
EPS RECONCILIATION
Basic/primary weighted average shares410410410
Basic/primary eps excl. extra items0.390.400.30
Basic/primary eps incl. extra items0.390.400.30
Dilution adjustment------
Diluted weighted average shares410410410
Diluted eps excl. extra items0.390.400.30
Diluted eps incl. extra items0.390.400.30
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.160.040
Gross dividend - common stock65170
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.760.500.74
SUPPLEMENTAL INCOME
Depreciation, supplemental503626
Total special items2013--
NORMALISED INCOME
Normalized income before taxes182187143
Effect of special items on income taxes0.300.68--
Income tax excluding impact of special items2.679.7118
Normalized income after tax179177125
Normalized income avail. to common179177125
Basic normalized EPS0.440.430.30
Diluted normalized EPS0.440.430.30
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.